Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C303393-5mg | 5mg | In stock | $64.90 | |
C303393-10mg | 10mg | In stock | $103.90 | |
C303393-25mg | 25mg | In stock | $207.90 | |
C303393-50mg | 50mg | In stock | $351.90 | |
C303393-100mg | 100mg | In stock | $626.90 |
Selective matrix metalloprotinase -13 (MMP-13) inhibitor
Synonyms | CL 82198 hydrochloride | DTXSID50587891 | J-018073 | N-(4-morpholinobutyl)benzofuran-2-carboxamide hydrochloride | 1188890-36-9 | NSC727677 | NSC-727677 | N-[4-(4-Morpholinyl)butyl]-2-benzofurancarboxamide hydrochloride | SCHEMBL13738786 | N-[4-(MORPHOLIN |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Selective MMP-13 inhibitor (IC 50 = 3.2 μM). Displays no activity against MMP-1, MMP-9 or TACE. Active in vivo . |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of MMP13 |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | product description: CL-82198 is a selective inhibitor of MMP-13. CL-82198 binds to the entire S1’ pocket of MMP-13, which is the basis for its selectivity towards MMP-13 and the lack of inhibitory activities against other MMPs. CL-82198 is a pharmacologic treatment for preventing osteoarthritis (OA) progression. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | N-(4-morpholin-4-ylbutyl)-1-benzofuran-2-carboxamide;hydrochloride |
---|---|
INCHI | InChI=1S/C17H22N2O3.ClH/c20-17(16-13-14-5-1-2-6-15(14)22-16)18-7-3-4-8-19-9-11-21-12-10-19;/h1-2,5-6,13H,3-4,7-12H2,(H,18,20);1H |
InChi Key | PIOACXKZWXHBRB-UHFFFAOYSA-N |
Canonical SMILES | C1COCCN1CCCCNC(=O)C2=CC3=CC=CC=C3O2.Cl |
Isomeric SMILES | C1COCCN1CCCCNC(=O)C2=CC3=CC=CC=C3O2.Cl |
PubChem CID | 16760373 |
Molecular Weight | 302.37 |
CAS Registry No. | 307002-71-7 |
---|---|
PubChem CID | 2777 |
ChEMBL Ligand | CHEMBL116757 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
K2209444 | Certificate of Analysis | Jul 11, 2022 | C303393 |
K2209452 | Certificate of Analysis | Jul 11, 2022 | C303393 |
K2209459 | Certificate of Analysis | Jul 11, 2022 | C303393 |
K2209467 | Certificate of Analysis | Jul 11, 2022 | C303393 |
K2209481 | Certificate of Analysis | Jul 11, 2022 | C303393 |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H302:Harmful if swallowed |
Precautionary Statements | P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P301+P317:IF SWALLOWED: Get medical help. |
1. George J et al.. (2017) MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice.. J Cell Mol Med, 21 (12): (3821-3835). [PMID:28782260] |